Iron and iron chelating agents modulate Mycobacterium tuberculosis growth and monocyte-macrophage viability and effector functions

FEMS Immunology and Medical Microbiology

Volumn 45, Issue 2, 2005, Pages 103-112

  Cronjé, Leandra ^a   Edmondson, Nicole ^a,b   Eisenach, Kathleen D ^b   Bornman, Liza ^a  

^a UNIVERSITY OF JOHANNESBURG   (South Africa)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Desferrioxamine; H37Rv; Iron chelation; Mycobacterium tuberculosis; Silybin

Indexed keywords

DEFEROXAMINE; DNA; IRON; IRON CHELATING AGENT; LIPOCORTIN 5; MESSENGER RNA; PHOSPHATIDYLSERINE; RIBOSOME RNA; SILIBININ; SUPEROXIDE;

ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIUM CULTURE; CELL VIABILITY; CHELATION THERAPY; COMPARATIVE STUDY; FLUORESCENCE; HOST CELL; INFECTION; IRON OVERLOAD; LIPOPHILICITY; MACROPHAGE; MITOCHONDRIAL MEMBRANE; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SUPPLEMENTATION;

BASE SEQUENCE; CELL SURVIVAL; DEFEROXAMINE; DNA, BACTERIAL; HUMANS; IRON; IRON CHELATING AGENTS; MACROPHAGES; MONOCYTES; MYCOBACTERIUM TUBERCULOSIS; SILYMARIN; U937 CELLS;

EID: 22844443827     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.femsim.2005.02.007     Document Type: Article

References (51)

1. H.L. Collins The role of iron in infections with intracellular bacteria Immunol. Lett. 85 2003 193 195
2. G. Weiss Iron and Immunity: a double-edged sword Eur. J. Clin. Invest. 32 2002 70 78
3. C. Ratledge Iron, mycobacteria and tuberculosis Tuberculosis (Edinb) 84 2004 110 130
4. Y.C. Manabe, B.J. Saviola, L. Sun, J.R. Murphy, and W.R. Bishai Attenuation of virulence in Mycobacterium tuberculosis expressing a constitutively active iron repressor Proc. Natl. Acad. Sci. USA 96 1999 12844 12848
5. G.M. Rodriques, M.I. Voskuil, B. Gold, G.K. Schoolnik, and I. Smith ideR, an essential gene in Mycobacterium tuberculosis: role of IdeR in iron-dependent gene expression, iron metabolism, and oxidative stress response Infect. Immun. 70 2002 3371 3381
6. G.M. Rodriguez, and I. Smith Mechanisms of iron regulation in mycobacteria: role in physiology and virulence Mol. Microbiol. 47 2003 1485 1494
7. S.T. Cole, R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S.V. Gordon, K. Eiglmeier, S. Gas, I.I.C. Barry, F. Tekai, K. Badcock, D. Basham, D. Brown, T. Chillingworth, R. Connor, R. Davies, K. Devlin, T. Feltwell, S. Gentles, N. Hamlin, S. Holroyd, T. Hornsby, K. Jagels, and B.G. Barrell Decipering the biology of Mycobacterium tuberculosis from the complete genome sequence Nature 393 1998 534 544
8. K.M. Edwards, M.H. Cynamon, R.K. Voladri, C.C. Hager, M.S. DeStefano, K.T. Tham, D.L. Lakey, M.R. Bochan, and D.S. Kernodle Iron-cofactored superoxide dismutase inhibits host responses to Mycobacterium tuberculosis Am. J. Respir. Crit. Care Med. 164 2001 2213 2219
9. B. Raghu, G.R. Sarma, and P. Venkatesan Effect of iron on the growth and siderophore production of mycobacteria Biochem. Mol. Biol. Int. 31 1993 341 348
10. J. Serafin-Lopez, R. Chacon-Salinas, S. Munoz-Cruz, J.A. Enciso-Moreno, S.A. Estrada-Parra, and I. Estrada-Garcia The effect of iron on the expression of cytokines in macrophages infected with Mycobacterium tuberculosis Scand. J. Immunol. 60 2004 329 337
11. N. Lounis, C. Truffot-Pernot, J. Grosset, V.R. Gordeuk, and J.R. Boelaert Iron and Mycobacterium tuberculosis infection J. Clin. Virol. 20 2001 123 126
12. V.R. Gordeuk, C.E. McLaren, A.P. MacPhail, G. Deichsel, and T.H. Bothwell Associations of iron overload in Africa with hepatocellular carcinoma and tuberculosis: Strachan's 1929 thesis revisited Blood 87 1996 3470 3476
13. I.T. Gangaidzo, V.M. Moyo, E. Mvundura, G. Aggrey, N.L. Murphee, H. Khumalo, T. Saungweme, I. Kasvosve, Z.R. Gomo, T. Rouault, J.R. Boelaert, and V.R. Gordeuk Association of pulmonary tuberculosis with increased dietary iron J. Infect. Dis. 184 2001 936 939
14. V.M. Moyo, I.T. Gangaidzo, V.R. Gordeuk, C.F. Kiire, and A.P. Macphail Tuberculosis and iron overload in Africa: a review Cent. Afr. J. Med. 43 1997 334 339
15. V.R. Gordeuk, A. Caleffi, E. Corradini, F. Ferrara, R.A. Jones, C. Castro, O. Onyekwere, R. Kittles, E. Pignatti, G. Montosi, C. Garuti, I.T. Gangaidzi, Z.A.R. Gomo, V.M. Moyo, T. Rouault, P. MacPhail, and A. Pietrangelo Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene Blood Cells Mol. Dis. 31 2003 299 304
16. V.M. Moyo, E. Mandishona, S.J. Hasstedt, I.T. Gangaidzo, Z.A.R. Gomo, H. Khumalo, T. Saungweme, C.F. Kiire, A.C. Paterson, P. Bloom, A.P. MacPhail, T. Rouault, and V.R. Gordeuk Evidence of genetic transmission in African iron overload Blood 91 1998 1076 1082
17. I. Kasvosve, I.T. Gangaidzo, Z.A. Gomo, and V.R. Gordeuk African iron overload Acta Clin. Belg. 55 2000 88 93
18. D.E. Kuhn, B.D. Baker, W.P. Lafuse, and B.S. Zwilling Differential iron transport into phagosomes isolated from the RAW264.7 macrophage cell lines transfected with Nramp1Gly169 or Nramp1Asp169 J. Leukoc. Biol. 66 1999 113 119
19. B.S. Zwilling, D.E. Kuhn, L. Wikoff, D. Brown, and W. Lafuse Role of iron in Nramp1-mediated inhibition of mycobacterial growth Infect. Immun. 67 1999 1386 1392
20. R. Bellamy, C. Ruwende, and T. Corrah Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene J. Infect. Dis 179 1999 721 724
21. A.C. Cervino, S. Lakiss, O. Sow, and A.V. Hill Allelic association between the NRAMP1 gene and susceptibility to tuberculosis in Guinea-Conakry Ann. Hum. Genet. 64 2000 507 512
22. J. Fitness, S. Floyd, D.K. Warndorff, L. Sichali, S. Malema, A.C. Crampin, P.E. Fine, and A.V. Hill Large-scale candidate gene study of tuberculosis susceptibility in the Karonga district of northern Malawi Am. J. Trop. Med. Hyg. 71 2004 341 349
23. G.F. Mabeza, M. Loyevsky, V.R. Gordeuk, and G. Weiss Iron chelation therapy for malaria: a review Pharmacol. Therapeutics. 81 1999 53 75
24. M. Sartori, S. Andorno, C. Rigamonti, and R. Boldorini Chronic hepatitis C treated with phlebotomy alone: biochemical and histological outcome Digest. Liv. Dis. 33 2001 157 162
25. N.A. Georgiou, T. van der Bruggen, M. Oudshoorn, H.M. Nottet, J.M. Marx, and B.S. van Asbeck Inhibition of human immunodeficiency virus type 1 replication in human mononuclear blood cells by the iron chelating agents deferoxamine, deferiprone, and bleomycin J. Infect. Dis. 181 2000 484 490
26. J. Rajiv, T. Dam, S. Kumar, M. Bose, K.K. Aggarwal, and C.R. Babu Inhibition of the in vitro growth of Mycobacterium tuberculosis by a phytosiderophore J. Med. Microbiol. 50 2001 916 918
27. G.S. Douvas, M.H. May, and A.J. Crowle Transferrin, iron, and serum lipids enhance or inhibit Mycobacterium avium replication in human macrophages J. Infect. Dis. 167 1993 857 864
28. M.S. Gomes, G. Dom, J. Pedrosa, J.R. Boelaert, and R. Appelberg Effects of iron deprivation on Mycobacterium avium growth Tuber Lung Dis. 79 1999 321 328
29. G.S. Douvas, M.H. May, A. Kolnagou, and G.J. Kontoghiorghes Effects on Mycobacterium avium replication in normal human macrophages by deferiprone (L1) and other iron chelating agents. Possible implications on toxicity Arzneimittelforschung 52 2002 45 52
30. M.S. Gomes, J.R. Boelaert, and R. Appelberg Role of iron in experimental Mycobacterium avium infection J. Clin. Virol. 20 2001 117 122
31. U.E. Schaible, H.L. Collins, F. Priem, and S.H.E. Kaufmann Correction of the iron overload defect in β-2-microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis J. Exp. Med. 196 2002 1507 1513
32. L. Cronjé, and L. Bornman Iron overload and tuberculosis: a case for iron chelation therapy Int. J. Tuberc. Lung Dis. 9 2005 1 8
33. M. Borsari, C. Gabbi, G. Ghelfi, R. Grand, M. Saladini, S. Severi, and F. Borella Silybin, a new iron-chelating agent J. Inorg. Biochem. 85 2001 123 129
34. Z. Varga, A. Czompa, G. Kakuk, and S. Antus Inhibition of the superoxide anion release and hydrogen peroxide formation in PMNLs by flavonolignans Phytother. Res. 15 2001 608 612
35. A. Pietrangelo, F. Borella, G. Casalgrandi, G. Montosi, D. Ceccarelli, D. Gallesi, F. Giovannini, A. Gasparetto, and A. Masini Antioxidant activity of silybin in vivo during long-term iron overload in rats Gastroenterology 109 1995 1941 1949
36. A. Tyagi, C. Agarwal, G. Harrison, L.M. Glode, and R. Agarwal Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI CDK-cyclin cascade, and caspase 3 and PARP cleavages Carcinogenesis 25 2004 1711 1720
37. Z. Varga, L. Ujhelyi, A. Kiss, J. Balla, A. Czompa, and S. Antus Effect of silybin on phorbol myristate actetate-induced protein kinase C translocation, NADPH oxidase activity and apoptosis in human neutrophils Phytomedicine 11 2004 206 212
38. H.G. Yoo, S.N. Jung, Y.S. Hwang, J.S. Park, M.H. Kim, M. Jeong, S.J. Ahn, B.W. Ahn, B.A. Shin, R.K. Park, and Y.D. Jung Involvement of NF-κB and caspases in silibinin-induced apoptosis of endothelial cells Int. J. Mol. Med. 13 2004 81 86
39. D.G. Lee, H.K. Kim, Y. Park, S.C. Park, E.R. Woo, H.G. Jeong, and K.S. Hahm Gram-positive bacteria specific properties of Silybin derived from Silybum marianum Arch. Pharm. Res. 26 2003 597 600
40. P. Bremner, and M. Heinrich Natural products as targeted modulators of the nuclear factor-kappaB pathway J. Pharm. Pharmacol. 54 2002 453 472
41. Y.K. Hodges, W.E. Antholine, and L.D. Horwitz Effect on ribonucleotide reductase of novel lipophilic iron chelating agents: the desferri-exochelins Biochem. Biophys. Res. Commun. 315 2004 595 598
42. T.J. Hellyer, L.E. DesJardin, G.L. Hehman, M.D. Cave, and K.D. Eisenach Quantitative analysis of mRNA as a marker for viability of Mycobacterium tuberculosis J. Clin. Microb. 37 1999 290 295
43. L.E. DesJardin, Y. Chen, M.D. Perkins, L. Teixeira, M.D. Cave, and K.D. Eisenach Comparison of the ABI 7700 system (TaqMan) and Competitive PCR for quantification of IS6110 DNA in sputum during treatment of tuberculosis J. Clin. Microbiol. 36 1998 1964 1968
44. L.E. DesJardin, Y. Chen, M.D. Perkins, L. Teixeira, M.D. Cave, and K.D. Eisenach Alkaline decontamination of sputum specimens adversely affects stability of mycobacterial mRNA J. Clin. Microbiol. 34 1996 2435 2439
45. L. Bornman, S. Baladi, M.J. Richard, R.M. Tyrrel, and B.S. Polla Differential regulation and expression of stress proteins and ferritin in human monocytes J. Cell Physiol. 178 1999 1 8
46. L. Caviedes, J. Delgado, and R.H. Gilman Tetrazolium microplate assay as a rapid and inexpensive colorimetric method for determination of antibiotic susceptibility of Mycobacterium tuberculosis J. Clin. Microbiol. 40 2002 1873 1874
47. O.J. Kwon The role of nitric oxide in the immune response to Tuberculosis JKMS 12 1999 481 487
48. J. Keane, H.G. Remold, and H. Kornfeld Virulent Mycobacterium tuberculosis strains evade apoptosis of alveolar macrophages J. Immunol. 164 2000 296 320
49. J.X. Xu Radical metabolism is partner to energy metabolism in mitochondria Ann. NY Acad. Sci. 1011 2004 57 60
50. Y. Zhengquan, H.L. Persson, J.W. Eaton, and U.T. Brunk Intralysosomal iron: a major determinant of oxidant-induced cell death Free Rad. Biol. Med. 34 2003 1243 1525
51. A. Molloy, P. Laochumroonvorapong, and G. Kaplan Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guerin J. Exp. Med. 180 1997 1499 1509